Lipodermatosclerosis · What Is It, Causes, Symptoms, and More

Published: Jan 06, 2026
Author: Lily Guo, MD
Editor: Alyssa Haag, MD
Editor: Emily Miao, PharmD, MD
Editor: Kelsey LaFayette, DNP, ARNP, FNP-C
Illustrator: Abbey Richard, MSc
7-day free trial

Go deeper with Osmosis

Osmosis is a learning platform with videos, questions, and AI tools to help you master topics like this.

4.8 · 12,000+ reviews
Watch quick, visual videos
Practice with Qbank-style questions
Use AI to explain, quiz, and review
Study anytime with the mobile app
Start free trial

No credit card · Cancel anytime

What is lipodermatosclerosis?

Lipodermatosclerosis, also known as lipomembranous panniculitis or sclerosing panniculitis, is a chronic skin condition characterized by inflammation of subcutaneous fat, primarily affecting the lower extremities. Lipodermatosclerosis is a form of panniculitis, which is a group of skin conditions that involve inflammation of subcutaneous tissue. While other areas such as the lower abdomen can be involved, most cases of lipodermatosclerosis involve the lower legs. Lipodermatosclerosis often affects middle-aged and older adults and is more common in genetic females 

Learn deeper with Osmosis

Master this topic faster with videos, questions, and AI.

Used by 8M+ healthcare learners.

Start free trial

No credit card · Cancel anytime

What causes lipodermatosclerosis?

The exact cause and pathogenesis of lipodermatosclerosis is unknown, however, it is closely associated with venous disease, including chronic venous insufficiencyDamage of the valves within the veins results in poor blood flow back to the heart and increased pressure in the veins, known as venous hypertension. The increased pressure facilitates the diffusion of fibrinogen, an inflammatory mediator, into the dermis, where it transforms into fibrin. Fibrin then forms a cuff around the capillaries, leading to hypoxia in the surrounding area. Additionally, increased venous pressure and inflammation of the vein wall cause increased production of matrix metalloproteinases (i.e., enzymes that break down protein) which can degrade collagen, contributing to the formation of venous ulcers. These physiologic changes can lead to changes in the skin's appearance, making it look indurated or hardened, thickened, and discolored. 

A history of deep vein thrombosis (DVT) can increase the risk of developing lipodermatosclerosis as it can result in damaged valves in the veins and lead to venous insufficiency. Obesity can also increase the risk of lipodermatosclerosis due to added pressure on the veins. Lifestyle choices (e.g., occupations that involve prolonged standing, sedentary lifestyle), advanced age, tobacco smoking, and hypercoagulable states (e.g., protein C or S deficiency) are additional risk factors 

What are the signs and symptoms of lipodermatosclerosis?

The signs and symptoms of lipodermatosclerosis can differ depending on whether the condition is in the acute, subacute, or chronic stage. If the symptoms are present for less than one month, it is considered acute lipodermatosclerosis and can present with tender, painful, erythematous, and localized plaques (i.e., skin lesions >1 centimeter [cm]). In up to half of cases, both legs are involved.  

Subacute lipodermatosclerosis, present for one month to one year, presents as nontender, hyperpigmented, sclerotic plaques. The hyperpigmentation is due to hemosiderin deposition, which is a protein that helps the body store iron. When it leaks out of damaged capillaries, this can result in a reddish-brown appearance of the skin. Often at this stage, non-healing venous ulcers can form on the legs above the ankle. The presence of varicose veins (i.e., visible, enlarged veins) is also common in acute to subacute lipodermatosclerosis.   

Chronic lipodermatosclerosis, which occurs when the skin condition is present for more than one year, results in the leg taking on a tapered appearance, often referred to as an ‘inverted champagne bottle’. The proximal leg is swollen and edematous whereas the lower leg closer to the ankle is slimmer, atrophied, and scarred from fat necrosis and chronic ulceration 

How is lipodermatosclerosis diagnosed?

A diagnosis of lipodermatosclerosis is often made based on clinical examination often by a dermatologist. They will often ask about one’s medical history including the individual’s lifestyle and occupation, history of blood clots, or smoking status. They will also perform a physical examination and document all skin changes that can help make a diagnosis of lipodermatosclerosis. Other clinical tests may be performed to help support the diagnosis including duplex ultrasound which can measure venous flow in the legs and identify signs of venous incompetence or deep vein thrombosis. Measuring the ankle-brachial pressure index (ABPI) can assess peripheral artery disease, whose clinical presentation can overlap with venous insufficiency. 

Other tests such as photoplethysmography, which measures capillary filling at rest and during exercise, can reveal elevated capillary filling due to venous reflux from damaged valves seen in lipodermatosclerosis. In cases of unusual presentation of disease, a skin biopsy may be performed, however, there is potential for poor wound healing due to decreased blood flow in the lower extremities 

How is lipodermatosclerosis treated?

Treatment of lipodermatosclerosis aims to prevent the progression of disease, improve blood flow, and reduce symptom severity. Typically, treatment starts with compression therapy, including the use of compression stockings or bandages to the affected areas to improve venous circulation. The individual may try to elevate their legs above their hearts as frequently as possible to reduce swelling and exercise regularly to increase blood flow throughout the body. Non-pharmacologic options such as emollients and moisturizers can help keep the skin hydrated and help prevent leg ulcers 

Topical medications such as corticosteroid cream (e.g., clobetasol propionate) can be used for anti-inflammatory purposes, and topical capsaicin cream can be used for pain relief. Intralesional (i.e., injections) triamcinolone acetonide can be used as treatment, however, it should be noted that it can cause skin lightening (i.e., hypopigmentation) in darker skin colors and skin atrophy with long-term use. Other medications including synthetic anabolic steroids (e.g., stanozolol, danazol, oxandrolone) help promote fibrinolysis, whereas pentoxifylline (i.e., an anti-fibrinolytic and vasodilator) and hydroxychloroquine can be used to improve edema and erythema.  

Ultrasound therapy, a noninvasive treatment where sound waves are used to penetrate the tissue and improve blood circulation, has been shown to reduce the induration and erythema of the legs and alleviate symptoms. In severe cases of lipodermatosclerosis, surgical intervention performed by a vascular surgeon or interventional radiologist may be necessary. Procedures such as vein stripping (i.e., the removal of a damaged vein) or valve repair might be required. 

What are the most important facts to know about lipodermatosclerosis?

Lipodermatosclerosis is a chronic skin condition marked by inflammation and hardening of the subcutaneous fat primarily of the lower legs. The condition often leads to indurated, thickened, and discolored skin. It is caused by factors such as chronic venous insufficiency, valve damage within veins leading to poor blood flow and increased pressure, and can be exacerbated by obesity, a history of deep vein thrombosis, and certain lifestyle factors. Symptoms vary across acute, subacute, and chronic stages, ranging from painful, erythematous plaques to hyperpigmented, sclerotic plaques, and ultimately to a tapered "inverted champagne bottle" appearance of the leg. Diagnosis is primarily clinical, supported by duplex ultrasound and other tests to assess venous flow and exclude other conditions. Treatment focuses on improving blood flow and managing symptoms, including compression therapy, leg elevation, regular exercise, and medications like corticosteroids and synthetic oral steroids. In severe cases, surgical interventions such as vein stripping or valve repair may be necessary. 

Key Takeaways

Definition 

Lipodermatosclerosis, also known as lipomembranous panniculitis or sclerosing panniculitis, is a chronic skin condition characterized by inflammation of subcutaneous fat, primarily affecting the lower extremities. It often affects middle-aged and older adults, and is more common in genetic females 

Causes  

- Exact pathogenesis unknown  

- Associated with venous disease 

     - Chronic venous insufficiency  

          - Damaged valves → venous hypertensionfibrin formation around capillaries and metalloproteinases production → tissue hypoxia and venous ulcers  

     - Risk factors 

          - History of DVT (→ venous insufficiency) 

          - Obesity  

          - Lifestyle (e.g., sedentary) 

          - Advanced age  

          - Tobacco smoking  

          - Hypercoagulable state 

Signs and Symptoms 

- Acute lipodermatosclerosis: symptoms for <1 month 

     - Tender, painful, erythematous, localized plaques (<1 cm) 

     - Both legs involved in up to half of cases 

- Subacute lipodermatosclerosis: symptoms for 1 month to 1 year 

     - Nontender, hyperpigmented (from hemosiderin deposition), sclerotic plaques  

     - Non-healing venous ulcers can form above the ankles  

- Chronic lipodermatosclerosis: symptoms for >1 year 

     - Tapered (“inverted champagne bottle”) appearance  

          - Lower leg slimmer, atrophied, and scarred from fat necrosis and chronic ulceration 

Diagnosis 

- Medical history  

- Physical examination (dermatologist) 

- Other tests:  

     - Duplex ultrasound  

     - Ankle-brachial pressure index (ABPI) (peripheral artery disease assessment) 

     - Photoplethysmography (capillary filling) 

     - Skin biopsy (but risk of poor would healing)  

Treatment 

- Compression therapy (stockings or bandages)  

- Leg elevation as frequently as possible  

- Emollients and moisturizers (leg ulcer prevention) 

- Topical medications (e.g., corticosteroid cream, capsaicin) 

- Intralesional triamcinolone acetonide cream (but can induce hypopigmentation and skin atrophy with long-term use) 

- Synthetic anabolic steroids (fibrinolysis promotion) 

- Pentoxifylline and hydroxychloroquine (edema and erythema prevention) 

- Ultrasound therapy (sound waves to improve blood circulation) 

- Surgery (e.g., vein stripping, valve repair) in severe cases 

Students say Osmosis is 100% worth it

Because Osmosis saves them time. Lowers stress. And actually helps them remember when it counts.

I used Osmosis to prepare for my first medical school licensing exam! Super helpful and interactive for people who may not do great with just pages of text info!

Cecilia Ruiz

Cecilia Ruiz

MD student

Sayan Misra

I have used Osmosis for about four years. Best thing I have ever used for my medical studies.

Sayan Misra

Sayan Misra

Med student

Osmosis videos are superior because they define simple concepts, tell a story with a clear progression, and provide context.

Jay Pate

Jay Pate

Dental student

References


Bruce AJ, Bennett DD, Lohse CM, Rooke TW, Davis MD. Lipodermatosclerosis: review of cases evaluated at Mayo Clinic. J Am Acad Dermatol. 2002 Feb;46(2):187-92.  


Charoen C, Suteeraporn C, Narachai J. Lipodermatosclerosis: a clinicopathologic correlation. Int J Dermatol. 2016;55(3):303–308. doi: 10.1111/ijd.12856. 


Damian DL, Yiasemides E, Gupta S, Armour K. Ultrasound therapy for lipodermatosclerosis. Arch Dermatol. 2009 Mar;145(3):330-2. doi: 10.1001/archdermatol.2009.24. PMID: 19289773.  


Fronek A, Minn C, Kim R. Venous outflow and inflow resistance in health and venous disease. J Vasc Surg. 2000 Mar;31(3):472-6. Erratum in: J Vasc Surg 2001 Jan;33(1):208. PMID: 10709059. 


Hassan I, Dorjay K, Anwar P. Pentoxifylline and its applications in dermatology. Indian Dermatol Online J. 2014 Oct;5(4):510-6. doi: 10.4103/2229-5178.142528. PMID: 25396144; PMCID: PMC4228656. 


MacColl E, Khalil RA. Matrix metalloproteinases as regulators of vein structure and function: Implications in chronic venous disease. J Pharmacol Exp Ther. 2015 Dec;355(3):410-28. doi: 10.1124/jpet.115.227330. Epub 2015 Aug 28. PMID: 26319699; PMCID: PMC4658486. 


Péret LA, Vidal HM, Gomes GAC, Oliveira GVB, Aguiar LM. Oxandrolone for treatment of lipodermatosclerosis: case report. J Vasc Bras. 2019 Oct 30;18:e20190031. doi: 10.1590/1677-5449.190031. PMID: 31723343; PMCID: PMC6830406. 


Wei E, Ting P, Barankin B, Tan B, Burgin S. Lipodermatosclerosis. VisualDx. Published September 14, 2021. Accessed February 4, 2024. Visualdx.com